The IgH 3' regulatory region and c-myc-induced B-cell lymphomagenesis

13Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

Deregulation and mutations of c-myc have been reported in multiple mature B-cell malignancies such as Burkitt lymphoma, myeloma and plasma cell lymphoma. After translocation into the immunoglobulin heavy chain (IgH) locus, c-myc is constitutively expressed under the control of active IgH cis-regulatory enhancers. Those located in the IgH 3' regulatory region (3'RR) are master control elements of transcription. Over the past decade numerous convincing demonstrations of 3'RR's contribution to mature c-myc-induced lymphomagenesis have been made using transgenic models with various types of IgH-c-myc translocations and transgenes. This review highlights how IgH 3'RR physiological functions play a critical role in c-myc deregulation during lymphomagenesis.

Cite

CITATION STYLE

APA

Ghazzaui, N., Saintamand, A., Issaoui, H., Vincent-Fabert, C., & Denizot, Y. (2017). The IgH 3’ regulatory region and c-myc-induced B-cell lymphomagenesis. Oncotarget. Impact Journals LLC. https://doi.org/10.18632/oncotarget.12535

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free